South Africa discloses Johnson & Johnson probe following press scrutiny

An “unprecedented” probe by South Africa’s competition watchdog is investigating whether Johnson & Johnson charged excessive prices and unlawfully blocked rivals from selling generic versions of its tuberculosis drug.

Unlock unlimited access to all Global Competition Review content